The U.S. Food and Drug Administration on Friday morning authorized the Pfizer-BioNTech and Moderna COVID-19 boosters for use in all adults, The Washington Post reports. The authorization is a "one-size-fits-all strategy" aimed at both hardening Americans' defenses against the virus" and "widening the booster campaign" to contend with a recent increase in cases, per the Post and The Wall Street Journal.
The Friday decision "essentially makes an additional dose a standard part of COVID-19 vaccinations now," writes the Journal, though some states have already expanded eligibility. Anyone 18 and older and at least six months past their second dose of the vaccine is qualified under the FDA's guidelines.
The move also reflects efforts to get ahead of waning vaccine efficacy, especially as the holidays approach, writes the Post.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The FDA will now pass the torch to the Centers for Disease Control and Prevention, which must also sign off on the authorization before its final approval. The agency is expected to make a decision in accordance with the FDA's by the end of Friday, possibly expanding booster access for millions of Americans as soon as this weekend.
-
The future of the Paris AgreementThe Explainer UN secretary general warns it is ‘inevitable’ the world will overshoot 1.5C target, but there is still time to change course
-
A scenic road trip in the French RivieraThe Week Recommends The mild climate of the Côte d’Azur makes it ideal for shoulder season
-
DC tourism has taken a hitUnder the Radar The government shutdown has reduced tourist attractions
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
